2014 annual financial data
Capricor Therapeutics 2014 Operating margin
Direct answer
Operating margin was -144.42%.
Operating income was -6,018,000 USD and net income was -6,217,000 USD.
Operating cash flow was 958,562 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,167,000 USD
- Operating income
- -6,018,000 USD
- Net income
- -6,217,000 USD
- Operating cash flow
- 958,562 USD